CNAs dominate the breast cancer genome, with NF1 gene amplification being a particular feature not seen in the other tumour types in which NF1 mutations are observed (Fig. 1), suggesting that gain of neurofibromin function is especially important in breast cancer biology. Here, NF1 is linked to neoplasm.